COMP <GO>
AVR vs SMTI // EV/EBITDA & P/E VALUATION
Anteris Technologies Global Corp. (NASDAQ) VS. Sanara MedTech Inc. (NASDAQ) • 15-METRIC TALLY: AVR 2
— SMTI 7
■ METRIC PARITY
LAST: $6.42 (+5.25%) • MKT CAP: $625.9M
valuation
—
LAST: $32.92 (+0.11%) • MKT CAP: $302.4M
valuation
29.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVR VS. SMTI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVR | SMTI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 70.30% | 92.70% | -22.40 | SMTI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 16.30% | -51.30 | SMTI | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 29.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -12.74% | 0.71% | -13.45 | SMTI | /fcf-yield <GO> |
| Operating Margin | -60.00% | 7.10% | -67.10 | SMTI | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 36.40% | -96.40 | SMTI | /net-margins <GO> |
| Revenue Growth (YoY) | -29.20% | 19.00% | -48.20 | SMTI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.25 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 7/9 | -5.00 | SMTI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.1 | 30.4 | +13.70 | AVR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 6.8x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $625.9M | $302.4M | $323.5M | AVR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVR REV | SMTI REV | AVR GROSS % | SMTI GROSS % | AVR FCF | SMTI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.9M | $103.1M | 70.3% | 92.7% | -$79.8M | $2.2M |
| FY 2024 | $2.7M | $86.7M | 46.8% | 90.6% | -$63.5M | -$229.6K |
| FY 2023 | — | $65.0M | — | — | — | -$3.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVR // BETA —
SMTI // BETA —